Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PTSD
Biotech
Lykos 'regrets' not disclosing study violations with publisher
Three articles related to Lykos' MDMA treatment have been retracted due to unethical conduct at a research site.
Gabrielle Masson
Aug 12, 2024 3:39pm
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Aug 10, 2024 9:07am
Compass tracks PTSD improvements in midphase psilocybin trial
May 8, 2024 8:07am
FDA advisers to weigh first psychedelic therapy in early June
May 7, 2024 11:10am
Neuropsych biotech Engrail closes $157M series B
Mar 19, 2024 8:00am
JPM's private capital team ‘actively looking’ at psychedelics
Feb 28, 2024 7:00am
